KRAS and pancreatic ductal adenocarcinoma: Son et al.129 demonstrated that KRAS-driven pancreatic ductal adenocarcinoma relies on glutamine catabolism to generate aspartate that is fuelled into the aspartate transaminase (GOT1)–malic enzyme 1 (ME1) axis, a major producer of NADPH.